Skip to search formSkip to main contentSkip to account menu

S 32504

Known as: S-32504, S32504 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Oxazines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP‐lesioned marmosets: Mediation by D2, not D3, dopamine receptors
L‐dopa remains the most common treatment for Parkinson's disease. However, there is considerable interest in D3/D2 receptor… 
2004
2004
Involvement of dopamine D(2)/D(3) receptors and BDNF in the neuroprotective effects of S32504 and pramipexole against 1-methyl-4-phenylpyridinium in terminally differentiated SH-SY5Y cells.
Anti-parkinsonian agents possessing both D(2) and D(3) receptor agonist properties are neuroprotective against 1-methyl-4… 
2003
2003
Behavioral effects of dopamine agonists and antagonists in MPTP-lesioned D3 receptor knockout mice
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)